Johns Hopkins researcher Michael DiStefano said the findings suggest pharma firms are pushing low-value drugs at consumers as part of a “strategy” to drive up patient demand for drugs clinicians could be less likely to prescribe.
Here’s Why Big Pharma Spends More On Ads Pushing Lower Benefit Drugs, Study Suggests
